BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17245425)

  • 1. Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation.
    Meyer E; Beyersmann J; Bertz H; Wenzler-Röttele S; Babikir R; Schumacher M; Daschner FD; Rüden H; Dettenkofer M;
    Bone Marrow Transplant; 2007 Feb; 39(3):173-8. PubMed ID: 17245425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project.
    Dettenkofer M; Wenzler-Röttele S; Babikir R; Bertz H; Ebner W; Meyer E; Rüden H; Gastmeier P; Daschner FD;
    Clin Infect Dis; 2005 Apr; 40(7):926-31. PubMed ID: 15824981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation.
    Dettenkofer M; Ebner W; Bertz H; Babikir R; Finke J; Frank U; Rüden H; Daschner FD
    Bone Marrow Transplant; 2003 May; 31(9):795-801. PubMed ID: 12732887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation.
    Zhu KE; Hu JY; Zhang T; Chen J; Zhong J; Lu YH
    Eur J Haematol; 2008 Dec; 81(6):461-6. PubMed ID: 18774951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy.
    Laurenti L; Tarnani M; Chiusolo P; La Torre G; Garzia M; Zollino M; Zini G; Balducci M; Leone G; Sica S
    Clin Transplant; 2008; 22(2):191-9. PubMed ID: 18339139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources.
    Walker CM; van Burik JA; De For TE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1106-15. PubMed ID: 17697973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation.
    Kim DH; Kumar D; Messner HA; Minden M; Gupta V; Kuruvilla J; Chae YS; Sohn SK; Lipton JH
    Clin Transplant; 2008; 22(6):770-9. PubMed ID: 18707605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of nosocomial infections in paediatric recipients of bone marrow or peripheral blood stem cell transplantation during neutropenia, compared with adult recipients.
    Laws HJ; Kobbe G; Dilloo D; Dettenkofer M; Meisel R; Geisel R; Haas R; Göbel U; Schulze-Röbbecke R
    J Hosp Infect; 2006 Jan; 62(1):80-8. PubMed ID: 16242206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.
    Kim DH; Messner H; Minden M; Gupta V; Kuruvilla J; Wright J; Lipton J
    Transpl Infect Dis; 2008 Apr; 10(2):90-8. PubMed ID: 17605742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
    Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
    Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors.
    Pabst C; Schirutschke H; Ehninger G; Bornhäuser M; Platzbecker U
    Clin Cancer Res; 2007 May; 13(10):2916-22. PubMed ID: 17504991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
    Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
    J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning.
    Grigg AP; Gibson J; Bardy PG; Reynolds J; Shuttleworth P; Koelmeyer RL; Szer J; Roberts AW; To LB; Kennedy G; Bradstock KF
    Biol Blood Marrow Transplant; 2007 May; 13(5):560-7. PubMed ID: 17448915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L; Styczynski J; Komarnicki M
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality.
    Poutsiaka DD; Price LL; Ucuzian A; Chan GW; Miller KB; Snydman DR
    Bone Marrow Transplant; 2007 Jul; 40(1):63-70. PubMed ID: 17468772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of potential risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with lymphoproliferative diseases.
    Auner HW; Zebisch A; Ofner P; Sill H; Linkesch W; Krause R
    Ann Hematol; 2005 Aug; 84(8):532-7. PubMed ID: 15809882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk.
    Worth LJ; Thursky KA; Seymour JF; Slavin MA
    Eur J Haematol; 2007 Sep; 79(3):226-33. PubMed ID: 17655696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance with successful reduction of central line-associated bloodstream infections among neutropenic patients with hematologic or oncologic malignancies.
    Chaberny IF; Ruseva E; Sohr D; Buchholz S; Ganser A; Mattner F; Gastmeier P
    Ann Hematol; 2009 Sep; 88(9):907-12. PubMed ID: 19139891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.